0001209191-17-039021.txt : 20170609 0001209191-17-039021.hdr.sgml : 20170609 20170609211107 ACCESSION NUMBER: 0001209191-17-039021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170607 FILED AS OF DATE: 20170609 DATE AS OF CHANGE: 20170609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kite Pharma, Inc. CENTRAL INDEX KEY: 0001510580 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 2225 COLORADO AVENUE CITY: SANTA MONICA STATE: CA ZIP: 90404 BUSINESS PHONE: (310) 824-9999 MAIL ADDRESS: STREET 1: 2225 COLORADO AVENUE CITY: SANTA MONICA STATE: CA ZIP: 90404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOUMANI ROY CENTRAL INDEX KEY: 0001230232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36508 FILM NUMBER: 17904229 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-07 0 0001510580 Kite Pharma, Inc. KITE 0001230232 DOUMANI ROY C/O KITE PHARMA, INC. 2225 SANTA MONICA AVENUE SANTA MONICA CA 90404 1 0 0 0 Common Stock 2017-06-07 4 S 0 10000 84.4621 D 155017 D Common Stock 2017-06-08 4 S 0 5000 84.5268 D 150017 D Common Stock 25065 I By spouse The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.265 to $85.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. /s/ David M. Tanen, Attorney-in-Fact 2017-06-09